A recent study highlights the need to continually monitor the cognitive development of children who were born very preterm.
Children born at a gestational age (GA) of 22 to 27 weeks are at significant risk of cognitive impairment at age 6.5 years, as are a substantial proportion of children born at a GA of 28-31 weeks. However, whereas neonatal conditions affect the prevalence of cognitive impairment of the former group (extremely preterm), these associations are not as evident in those in the latter group (very pre-term), according to a recent study.
Swedish investigators divided pre- term infants into 2 groups—those born extremely preterm (EPT) and those born very preterm (VPT). They assessed both groups for neurodevelopment at age 2.5 years and for cognitive outcomes at 6.5 years. Both assessments revealed mild-to-severe neurodevelopmental impairment. At 6.5 years, 8 of 91 children tested were diagnosed with cerebral palsy (4 VPT and4EPT)and6(4VPTand2EPT) with autism. Three of these 14 children had both cerebral palsy and autism. Neonatal factors independently related to 6.5-year outcomes were GA, retinopathy of prematurity, and treated persistent ductus arteriosus. But cognitive test scores at 2.5 years explained only 44% of intelligence score variance at 6.5 years. Given these results, the authors recommend following up into school age all children born before 32 weeks’ GA.
Thoughts from Dr. Farber
The test results at 2.5 years were corrected for prematurity. Although correction may be valid for younger children, I have always been leery that it is misleading by 2.5 years, presenting an overly optimistic picture. Unless the cognitive development of an extremely preterm child is solidly normal at 2.5 years, he or she still needs to be monitored closely.
Reference
1. Kaul YF, Naseh N, Brodd KS, Böhm B, Holmström G, Hellström-Westas L. Average 2.5-year neurodevelop- mental test results in children born very preterm did not rule out cognitive deficits at 6.5 years of age. Acta Paediatr. 2021;110(3):846-854. doi:10.1111/apa.15586
Stress ulcer prophylaxis does not provide prevention of gastrointestinal bleeding in neonates
December 4th 2023In a poster abstract presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting & Exhibition held in Anaheim, California, stress ulcer prophylaxis (SUP) did not appear to provide benefit for prevention of gastrointestinal bleeding and did not increase SUP-associated adverse effects.
Hematocrit levels in newborns: EPP vs DCC study reveals surprising findings
November 15th 2023A recent study in JAMA Network Open investigates the impact of extrauterine placental perfusion versus delayed cord clamping on hematocrit levels in newborns, shedding light on potential alternatives for optimizing infant outcomes during birth.
Preterm infant HRQOL: Long-term impacts and determinants
October 21st 2023A recent study was highlighted at the 2023 American Academy of Pediatrics National Conference & Exhibition that shed light on the long-term impact of very preterm birth on the health-related quality of life (HRQOL) of infants and identified key determinants.
Associations between prenatal metal mixture exposure and negative infant outcomes
September 19th 2023Francheska M. Merced-Nieves, PhD, Assistant professor, Departments of Pediatrics and the Institute for Exposomic Research of Environmental Medicine & Public Health, Icahn School of Medicine at Mount Sinai, explains the associations prenatal exposure to a metal mixture and the potential negative effects for the infant.